Capra Biosciences
Americas
Sterling
,
United States
Scaleup
FOUNDED
2020
HEADCOUNT
21-100
FUNDING
Pre-seed
Keywords:
bioreactor_design, specialty_chemicals, cosmetics, therapeutics
BUSINESS
Develops biofilm bioreactor technology for biological production of renewable chemicals from waste. Capra Biosciences is a Sterling, Virginia-based startup founded in 2020 that produces bio-derived small molecule chemicals as replacements for petrochemical-derived products. Their first commercial products are retinol and salicylic acid for personal care; they also secured a $7.5M BioMaP-Consortium project agreement to demonstrate rapid scale-up of bio-derived active pharmaceutical ingredients.
BIOTECH INVOLVEMENT
Core; Virginia startup (2020) operating a proprietary biofilm bioreactor for biological production of renewable small-molecule chemicals from waste, currently focused on cosmetic and specialty actives.
TECHNOLOGY PLATFORM
Biofilm bioreactors; biosynthesis
PRIMARY PRODUCTS
Bio-based retinol, salicylic acid and hydrophobic chemicals